EUCTR2007-001139-71-IT进行中（未招募）不适用
A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-894, Duloxetine and Placebo in Subjects with Diabetic Neuropathic Pain - ND
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 275
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Look at Synopsis Main Inclusion Criteria (1-12)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Look at Synopsis:Main Exclusion Criteria(1-18)
研究者
相似试验
进行中（未招募）
不适用
A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-894 versus Placebo in Subjects with Diabetic Neuropathic Paidiabetic neuropathic painMedDRA version: 9.1Level: LLTClassification code 10054095Term: Neuropathic painEUCTR2007-001140-47-CZAbbott GmbH & Co. KG110
进行中（未招募）
1 期
A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-894 versus Placebo in Subjects with Diabetic Neuropathic Paidiabetic neuropathic painMedDRA version: 9.1Level: LLTClassification code 10054095Term: Neuropathic painEUCTR2007-001140-47-FRAbbott GmbH & Co. KG110
进行中（未招募）
1 期
A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-894, Duloxetine and Placebo in Subjects with Diabetic Neuropathic Paidiabetic neuropathic painMedDRA version: 9.1Level: LLTClassification code 10054095Term: Neuropathic painEUCTR2007-001139-71-FRAbbott GmbH & Co. KG275
进行中（未招募）
不适用
A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-894 versus Placebo in Subjects with Diabetic Neuropathic PaiEUCTR2007-001140-47-GBAbbott GmbH & Co. KG110
进行中（未招募）
不适用
A Global, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of ABT-894, Duloxetine and Placebo in Subjects with Diabetic Neuropathic PaiEUCTR2007-001139-71-DEAbbott GmbH & Co. KG275